One previous study showed that targeted disruption of β-catenin significantly blocked FGF18 expression [33], while another found that β-catenin is capable of enhancing FGF18 transcription in colon cancer from the promoter of FGF18 harboring TCF4-binding motifs [26]. The gene discussed is TCF4; the disease is malignant colon neoplasm.